FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896003784> ?p ?o ?g. }

• W2896003784 endingPage "212" @default.
• W2896003784 startingPage "203" @default.
• W2896003784 abstract "Background: According to WHO, in 2017, about 90.5 million people suffered from cancer and about 8.8 million deaths occurred due to disease. Although the chemotherapeutic agents have decreased the mortality among the cancer patients but high toxicity and non-specific targets are still major drawbacks. : Many researchers have identified linomide, a 4-hydroxy-2-quinolone derivative, as a lead molecule for the development of anticancer agents. With this background, we thought of the following objective. Objective: The objective of this research work involves the synthesis of a series of N-(2-(4- hydroxy-2-oxo-1-phenyl-1,2-dihydroquinolin-3-yl)-2-oxoethyl)-N-alkyl substituted benzene sulfonamides IVa-d (1-3) by replacing the anilide moiety at the third position of linomide with sulfamoylacyl and also N-methyl by N-phenyl functionality. To perform in silico anticancer activity by using Molegro Virtual Docker (MVD-2013, 6.0) software and in vitro anticancer activity by MTT assay. Methods: The starting material 4-hydroxy-1-phenylquinolin-2(1H)-one was treated with N-bromosuccinamide to yield compound II. Condensation of compound II with primary amines resulted in compounds IIIa-d, which, on coupling with substituted aromatic sulfonyl chlorides yield the title compounds IVa-d (1-3). Results: All the synthesized compounds were satisfactorily characterized by spectral data. The results of docking revealed that the synthesized compounds exhibited well-conserved hydrogen bonds with one or more amino acid residues in the active pocket of EGFRK tyrosine kinase domain (PDB ID: 1m17). The MolDock Score of compound IVd-1 (-115.503) was the highest amongst those tested. The in vitro anticancer activity results showed that compound IVc-1 (R= - (CH2) 2-CH3 ; R′= -H) and IV d-1 (R= -CH2-C6H5; R′= -H) were found to be most potent against K562 cell line with an IC50 of 0.451 μM/ml and 0.455 μM/ml respectively. Compound IVd-1 also showed better potency against A549 cell line with IC50 value of 0.704 μM/ml. Conclusion: The results of in silico and in vitro anticancer activity are in agreement with each other. Compound IV d-1 was found to be most active of the series." @default.
• W2896003784 created "2018-10-26" @default.
• W2896003784 creator A5011821677 @default.
• W2896003784 creator A5037665778 @default.
• W2896003784 creator A5075183440 @default.
• W2896003784 creator A5087635250 @default.
• W2896003784 date "2020-06-19" @default.
• W2896003784 modified "2023-10-16" @default.
• W2896003784 title "Design, Synthesis, and Characterization of Novel Linomide Analogues and their Evaluation for Anticancer Activity" @default.
• W2896003784 cites W1979020782 @default.
• W2896003784 cites W1996308650 @default.
• W2896003784 cites W2015477517 @default.
• W2896003784 cites W2029681458 @default.
• W2896003784 cites W2032430882 @default.
• W2896003784 cites W2046013235 @default.
• W2896003784 cites W2048008261 @default.
• W2896003784 cites W2075016350 @default.
• W2896003784 cites W2094445428 @default.
• W2896003784 cites W2106635136 @default.
• W2896003784 cites W2106787323 @default.
• W2896003784 doi "https://doi.org/10.2174/1570163815666181008151037" @default.
• W2896003784 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30306874" @default.
• W2896003784 hasPublicationYear "2020" @default.
• W2896003784 type Work @default.
• W2896003784 sameAs 2896003784 @default.
• W2896003784 citedByCount "3" @default.
• W2896003784 countsByYear W28960037842022 @default.
• W2896003784 crossrefType "journal-article" @default.
• W2896003784 hasAuthorship W2896003784A5011821677 @default.
• W2896003784 hasAuthorship W2896003784A5037665778 @default.
• W2896003784 hasAuthorship W2896003784A5075183440 @default.
• W2896003784 hasAuthorship W2896003784A5087635250 @default.
• W2896003784 hasConcept C159110408 @default.
• W2896003784 hasConcept C178790620 @default.
• W2896003784 hasConcept C185592680 @default.
• W2896003784 hasConcept C202751555 @default.
• W2896003784 hasConcept C21951064 @default.
• W2896003784 hasConcept C2776568683 @default.
• W2896003784 hasConcept C2777752112 @default.
• W2896003784 hasConcept C2779922871 @default.
• W2896003784 hasConcept C2780263894 @default.
• W2896003784 hasConcept C2780783641 @default.
• W2896003784 hasConcept C41685203 @default.
• W2896003784 hasConcept C501593827 @default.
• W2896003784 hasConcept C55493867 @default.
• W2896003784 hasConcept C71240020 @default.
• W2896003784 hasConcept C71924100 @default.
• W2896003784 hasConcept C87906975 @default.
• W2896003784 hasConcept C98274493 @default.
• W2896003784 hasConceptScore W2896003784C159110408 @default.
• W2896003784 hasConceptScore W2896003784C178790620 @default.
• W2896003784 hasConceptScore W2896003784C185592680 @default.
• W2896003784 hasConceptScore W2896003784C202751555 @default.
• W2896003784 hasConceptScore W2896003784C21951064 @default.
• W2896003784 hasConceptScore W2896003784C2776568683 @default.
• W2896003784 hasConceptScore W2896003784C2777752112 @default.
• W2896003784 hasConceptScore W2896003784C2779922871 @default.
• W2896003784 hasConceptScore W2896003784C2780263894 @default.
• W2896003784 hasConceptScore W2896003784C2780783641 @default.
• W2896003784 hasConceptScore W2896003784C41685203 @default.
• W2896003784 hasConceptScore W2896003784C501593827 @default.
• W2896003784 hasConceptScore W2896003784C55493867 @default.
• W2896003784 hasConceptScore W2896003784C71240020 @default.
• W2896003784 hasConceptScore W2896003784C71924100 @default.
• W2896003784 hasConceptScore W2896003784C87906975 @default.
• W2896003784 hasConceptScore W2896003784C98274493 @default.
• W2896003784 hasIssue "2" @default.
• W2896003784 hasLocation W28960037841 @default.
• W2896003784 hasOpenAccess W2896003784 @default.
• W2896003784 hasPrimaryLocation W28960037841 @default.
• W2896003784 hasRelatedWork W1995169129 @default.
• W2896003784 hasRelatedWork W2044483947 @default.
• W2896003784 hasRelatedWork W2258029851 @default.
• W2896003784 hasRelatedWork W2354559271 @default.
• W2896003784 hasRelatedWork W2734999807 @default.
• W2896003784 hasRelatedWork W2787170880 @default.
• W2896003784 hasRelatedWork W2885104721 @default.
• W2896003784 hasRelatedWork W2975486690 @default.
• W2896003784 hasRelatedWork W3118751974 @default.
• W2896003784 hasRelatedWork W3137876727 @default.
• W2896003784 hasVolume "17" @default.
• W2896003784 isParatext "false" @default.
• W2896003784 isRetracted "false" @default.
• W2896003784 magId "2896003784" @default.
• W2896003784 workType "article" @default.